Beijing Li Er (002392), Lik Sang pharmaceuticals (002393) of the shares (002394) today released an offer letter of intent, officially launched IPO.
Beijing profit, company executives will take place April 6 roadshow team in Shanghai, Shenzhen and Beijing launched a preliminary inquiry and roadshow promotion work. In accordance with the programme, Lear sell 33.75 million shares shares on the Shenzhen Stock Exchange, 25% per cent of total shares after this release. Companies will be conducted between April 6 and inquiry. April 13 to offline purchase, payment and issuing purchase online today.
Beijing superior domestic refractories for iron and steel industry as a whole contracted business model first, is the nation's largest collection of materials in the design, development, configuration, installation, construction, maintenance, manufacturing, facilities, as one of the "full online service" one of refractories for iron and steel industry as a whole contracted suppliers. Companies raise investment projects include the annual production capacity of 10,000 tons of functional refractories for continuous casting, annual production capacity of 45,000 tons of high quality refractory materials for external refining and an annual output of 10,000 tons high-grade ceramic fibers and products. Company, offering investment and project products are high-tech products represent the refractory industry development direction, belonging to the upgrading of refractory products, have good market prospects and good profitability.
Lik Sang pharmaceuticals that have been a nearly 60-year history of the plan to issue 46 million shares, after the release of the total share capital of 25.21%. The company is the medical systems of large enterprises in Tianjin, is the synthesis of pharmaceutical and chemical preparations production an important one. Company is mainly engaged in chemical medicine tablets, hard capsules, granules, pills, production and sales of products such as raw materials, daily production of more than more than 20 categories, more than 100 varieties of specifications of the dosage.
Lik Sang pharmaceuticals which, raises funds wholly-owned subsidiaries of Tianjin is mainly used in subordinate industrialization projects of new pharmaceutical chemical raw material drug company, new pharmaceutical chemical pharmaceutical preparations production research and development projects, as well as the acquisitions group biochemical pharmaceutical companies 48% interests.
UNDAF intends to sell 27 million shares shares shares, raise money for 4 items, including high-grade fabric zhiran and finishing technical innovation project, high grade special natural fiber yarn production line technical innovation project, high-class shirts hanging assembly line technology project, dyed textile research and Development Center construction project in Jiangsu Province, total proceeds amount to $ 736 million.
No comments:
Post a Comment